DrugPatentWatch Database Preview
Drugs in Development Information for Vadadustat
Email this page to a colleague
What is the development status for investigational drug Vadadustat?
Vadadustat is an investigational drug.
There have been 27 clinical trials for Vadadustat.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Anemia, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are Akebia Therapeutics, Mitsubishi Tanabe Pharma Corporation, and The University of Texas Health Science Center, Houston.
There are twenty-nine US patents protecting this investigational drug and two hundred and fifty-nine international patents.
Summary for Vadadustat
| US Patents | 29 |
| International Patents | 259 |
| US Patent Applications | 68 |
| WIPO Patent Applications | 42 |
| Japanese Patent Applications | 20 |
| Clinical Trial Progress | Phase 3 (2015-12-01) |
| Vendors | 35 |
Recent Clinical Trials for Vadadustat
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects | Akebia Therapeutics | Phase 3 |
| Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | Akebia Therapeutics Inc. | Phase 2 |
| Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | The University of Texas Health Science Center, Houston | Phase 2 |
Clinical Trial Summary for Vadadustat
Top disease conditions for Vadadustat
Top clinical trial sponsors for Vadadustat
US Patents for Vadadustat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vadadustat | Try Before You Buy | Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof | SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (Shenyang, Liaoning, CN) | Try Before You Buy |
| Vadadustat | Try Before You Buy | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | Try Before You Buy |
| Vadadustat | Try Before You Buy | Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof | SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (Shenyang, CN) | Try Before You Buy |
| Vadadustat | Try Before You Buy | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | Akebia Therapeutics, Inc. (Cambridge, MA) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vadadustat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vadadustat | China | CN106146490 | 2035-03-27 | Try Before You Buy |
| Vadadustat | European Patent Office | EP3275881 | 2035-03-27 | Try Before You Buy |
| Vadadustat | Japan | JP2018513144 | 2035-03-27 | Try Before You Buy |
| Vadadustat | Japan | JP6556861 | 2035-03-27 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
